Courier Capital LLC Ampio Pharmaceuticals, Inc. Transaction History

Courier Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$0.16 - $0.47 $12,112 - $35,579	75,700 Added 16.3%	540,056 $91,000
Q4 2021 Jan 18, 2022	BUY	$0.56 - $1.71 $38,080 - $116,280	68,000 Added 17.16%	464,356 $265,000
Q2 2021 Jul 12, 2021	BUY	$1.56 - $1.98 $25,557 - $32,438	16,383 Added 4.31%	396,356 $662,000
Q4 2020 Feb 10, 2021	SELL	$0.75 - $2.76 $12,287 - $45,217	-16,383 Reduced 4.13%	379,973 $604,000
Q3 2020 Nov 09, 2020	BUY	$0.61 - $1.17 $9,993 - $19,168	16,383 Added 4.31%	396,356 $337,000
Q2 2019 Jul 16, 2019	BUY	$0.39 - $0.7 $9,750 - $17,500	25,000 Added 7.04%	379,973 $147,000
Q4 2018 Feb 08, 2019	BUY	$0.39 - $0.7 $19,500 - $35,000	50,000 Added 16.39%	354,973 $140,000
Q3 2018 Oct 12, 2018	BUY	$0.44 - $3.02 $127,896 - $877,832	290,673 Added 2032.68%	304,973 $155,000
Q2 2017 Aug 10, 2017	BUY	N/A	14,300	14,300 $7,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Courier Capital LLC with notifications on news.